BriaCell Therapeutics Corp (BCTXW) — Long-term Investment Intensity
BriaCell Therapeutics Corp (BCTXW) has a Long-term Investment Intensity of 1.7% as of January 2026. Long-term investments of $582.46K represent 1.7% of total assets of $33.31 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of BriaCell Therapeutics Corp to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BriaCell Therapeutics Corp Long-term Investment Intensity (2017–2024)
This chart shows how BriaCell Therapeutics Corp's Long-term Investment Intensity has evolved across 8 annual periods from 2017 to 2024. As of January 2026, the intensity stands at 1.7%, reflecting long-term investments of $582.46K against total assets of $33.31 Million USD. Explore how well can BriaCell Therapeutics Corp service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for BriaCell Therapeutics Corp (2017–2024)
The table below presents the year-by-year Long-term Investment Intensity for BriaCell Therapeutics Corp from 2017 to 2024, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BCTXW company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 7.1% | $418.49K | $5.87 Million | ▲ +7.1 pp |
| 2023 | 0.0% | $2.00 | $27.16 Million | ▲ +0.0 pp |
| 2022 | 0.0% | $2.00 | $42.58 Million | ▲ +0.0 pp |
| 2021 | 0.0% | $2.00 | $58.04 Million | ▼ 0.0 pp |
| 2020 | 0.0% | $2.00 | $478.31K | ▼ 0.0 pp |
| 2019 | 0.0% | $2.00 | $415.43K | ▲ +0.0 pp |
| 2018 | 0.0% | $2.00 | $2.28 Million | ▼ 0.0 pp |
| 2017 | 0.0% | $2.00 | $1.64 Million | — |